RANDOMISED TRIAL OF INTRAVENOUS ATENOLOL AMONG 16 027 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-1
- 12 July 1986
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 328 (8498), 57-66
- https://doi.org/10.1016/s0140-6736(86)91607-7
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trialEuropean Heart Journal, 1985
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985
- Beta blockers after myocardial infarction: have trials changed practice?BMJ, 1984
- Why do we need some large, simple randomized trials?Statistics in Medicine, 1984
- PREVENTION OF VENTRICULAR FIBRILLATION DURING ACUTE MYOCARDIAL INFARCTION BY INTRAVENOUS PROPRANOLOLThe Lancet, 1984
- Enhancement of salvage of reperfused myocardium by early beta-adrenergic blockade (timolol)Journal of the American College of Cardiology, 1984
- Reduction of ventricular arrhythmias by early intravenous atenolol in suspected acute myocardial infarction.BMJ, 1983
- Limitation of myocardial infarct size in patients less than 66 years treated with alprenolol.Heart, 1981
- EFFECT OF ALPRENOLOL ON MORTALITY AMONG PATIENTS WITH DEFINITE OR SUSPECTED ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1979
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and designBritish Journal of Cancer, 1976